APO RESEARCH · REPORT
NAC (Acetylcisteine)
Acetylcysteine (NAC) is the N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.
Product & engineering
Understand the product.
Acetylcysteine (NAC) is the N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.
Selected research
Industry Growth & Trends
Global NAC (Acetylcisteine) Industry Growth and Trends Forecast to 2032
Market perspective
Acetylcysteine (NAC) is the N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.
Zambon, Nippon Rika, Pharmazell, etc. are the major manufacturers in the global NAC (Acetylcisteine) market and the top three players hold about 13% of the total share.
According to the consumption region, North America and Europe have a good prospect and they have about 28%, 28% respectively. Besides, China, Japan, and some other regions also play an important role in this market.
Read the full market overview
Based on the type, 98%~99% dominates the market and holds more than 65 percent of the global total share, the rest part is Above 99%. And according to the application, Pharmaceutical is the largest application in this market, which accounts for more than 60%.
Report Scope
This report provides a structured, data-driven view of the global NAC (Acetylcisteine) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The NAC (Acetylcisteine) market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NAC (Acetylcisteine) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NAC (Acetylcisteine).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global NAC (Acetylcisteine) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
NAC (Acetylcisteine) Market by Company
Zambon
Nippon Rika
Pharmazell
Kyowa Hakko
Shine Star Biological
Moehs
Chengyi Pharma
Wuhan Grand Hoyo
Donboo Amino Acid
Huachang Pharmaceutical
Xinyi Hanling Biological
Shuguang Biological
Scandinavian Formulas
NAC (Acetylcisteine) Segment by Type
98%~99%
Above 99%
NAC (Acetylcisteine) Segment by Application
Nutritional Supplements
Pharmaceutical
Others
NAC (Acetylcisteine) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAC (Acetylcisteine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAC (Acetylcisteine) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAC (Acetylcisteine).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NAC (Acetylcisteine) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of NAC (Acetylcisteine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 98%~99%
- Above 99%
Applications
- Nutritional Supplements
- Pharmaceutical
- Others
Companies covered
- Zambon
- Nippon Rika
- Pharmazell
- Kyowa Hakko
- Shine Star Biological
- Moehs
- Chengyi Pharma
- Wuhan Grand Hoyo
- Donboo Amino Acid
- Huachang Pharmaceutical
- Xinyi Hanling Biological
- Shuguang Biological
- Scandinavian Formulas
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global NAC (Acetylcisteine) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global NAC (Acetylcisteine) Sales Estimates and Forecasts (2021-2032)
- 1.3 NAC (Acetylcisteine) Market by Type
- 1.3.1 98%~99%
- 1.3.2 Above 99%
- 1.4 Global NAC (Acetylcisteine) Market Size by Type
- 1.4.1 Global NAC (Acetylcisteine) Market Size Overview by Type (2021-2032)
- 1.4.2 Global NAC (Acetylcisteine) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global NAC (Acetylcisteine) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America NAC (Acetylcisteine) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe NAC (Acetylcisteine) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific NAC (Acetylcisteine) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America NAC (Acetylcisteine) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa NAC (Acetylcisteine) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 NAC (Acetylcisteine) Industry Trends
- 2.2 NAC (Acetylcisteine) Industry Drivers
- 2.3 NAC (Acetylcisteine) Industry Opportunities and Challenges
- 2.4 NAC (Acetylcisteine) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by NAC (Acetylcisteine) Revenue (2021-2026)
- 3.2 Global Top Players by NAC (Acetylcisteine) Sales (2021-2026)
- 3.3 Global Top Players by NAC (Acetylcisteine) Price (2021-2026)
- 3.4 Global NAC (Acetylcisteine) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global NAC (Acetylcisteine) Major Company Production Sites & Headquarters
- 3.6 Global NAC (Acetylcisteine) Company, Product Type & Application
- 3.7 Global NAC (Acetylcisteine) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global NAC (Acetylcisteine) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 NAC (Acetylcisteine) Players Market Share by Revenue in 2025
- 3.8.3 2025 NAC (Acetylcisteine) Tier 1, Tier 2, and Tier 3
4 NAC (Acetylcisteine) Regional Status and Outlook
- 4.1 Global NAC (Acetylcisteine) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global NAC (Acetylcisteine) Historic Market Size by Region
- 4.2.1 Global NAC (Acetylcisteine) Sales in Volume by Region (2021-2026)
- 4.2.2 Global NAC (Acetylcisteine) Sales in Value by Region (2021-2026)
- 4.2.3 Global NAC (Acetylcisteine) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global NAC (Acetylcisteine) Forecasted Market Size by Region
- 4.3.1 Global NAC (Acetylcisteine) Sales in Volume by Region (2027-2032)
- 4.3.2 Global NAC (Acetylcisteine) Sales in Value by Region (2027-2032)
- 4.3.3 Global NAC (Acetylcisteine) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NAC (Acetylcisteine) by Application
- 5.1 NAC (Acetylcisteine) Market by Application
- 5.1.1 Nutritional Supplements
- 5.1.2 Pharmaceutical
- 5.1.3 Others
- 5.2 Global NAC (Acetylcisteine) Market Size by Application
- 5.2.1 Global NAC (Acetylcisteine) Market Size Overview by Application (2021-2032)
- 5.2.2 Global NAC (Acetylcisteine) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global NAC (Acetylcisteine) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America NAC (Acetylcisteine) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe NAC (Acetylcisteine) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific NAC (Acetylcisteine) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America NAC (Acetylcisteine) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa NAC (Acetylcisteine) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zambon
- 6.1.1 Zambon Company Information
- 6.1.2 Zambon Business Overview
- 6.1.3 Zambon NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zambon NAC (Acetylcisteine) Product Portfolio
- 6.1.5 Zambon Recent Developments
- 6.2 Nippon Rika
- 6.2.1 Nippon Rika Company Information
- 6.2.2 Nippon Rika Business Overview
- 6.2.3 Nippon Rika NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Nippon Rika NAC (Acetylcisteine) Product Portfolio
- 6.2.5 Nippon Rika Recent Developments
- 6.3 Pharmazell
- 6.3.1 Pharmazell Company Information
- 6.3.2 Pharmazell Business Overview
- 6.3.3 Pharmazell NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pharmazell NAC (Acetylcisteine) Product Portfolio
- 6.3.5 Pharmazell Recent Developments
- 6.4 Kyowa Hakko
- 6.4.1 Kyowa Hakko Company Information
- 6.4.2 Kyowa Hakko Business Overview
- 6.4.3 Kyowa Hakko NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Kyowa Hakko NAC (Acetylcisteine) Product Portfolio
- 6.4.5 Kyowa Hakko Recent Developments
- 6.5 Shine Star Biological
- 6.5.1 Shine Star Biological Company Information
- 6.5.2 Shine Star Biological Business Overview
- 6.5.3 Shine Star Biological NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Shine Star Biological NAC (Acetylcisteine) Product Portfolio
- 6.5.5 Shine Star Biological Recent Developments
- 6.6 Moehs
- 6.6.1 Moehs Company Information
- 6.6.2 Moehs Business Overview
- 6.6.3 Moehs NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Moehs NAC (Acetylcisteine) Product Portfolio
- 6.6.5 Moehs Recent Developments
- 6.7 Chengyi Pharma
- 6.7.1 Chengyi Pharma Company Information
- 6.7.2 Chengyi Pharma Business Overview
- 6.7.3 Chengyi Pharma NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Chengyi Pharma NAC (Acetylcisteine) Product Portfolio
- 6.7.5 Chengyi Pharma Recent Developments
- 6.8 Wuhan Grand Hoyo
- 6.8.1 Wuhan Grand Hoyo Company Information
- 6.8.2 Wuhan Grand Hoyo Business Overview
- 6.8.3 Wuhan Grand Hoyo NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Wuhan Grand Hoyo NAC (Acetylcisteine) Product Portfolio
- 6.8.5 Wuhan Grand Hoyo Recent Developments
- 6.9 Donboo Amino Acid
- 6.9.1 Donboo Amino Acid Company Information
- 6.9.2 Donboo Amino Acid Business Overview
- 6.9.3 Donboo Amino Acid NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Donboo Amino Acid NAC (Acetylcisteine) Product Portfolio
- 6.9.5 Donboo Amino Acid Recent Developments
- 6.10 Huachang Pharmaceutical
- 6.10.1 Huachang Pharmaceutical Company Information
- 6.10.2 Huachang Pharmaceutical Business Overview
- 6.10.3 Huachang Pharmaceutical NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Huachang Pharmaceutical NAC (Acetylcisteine) Product Portfolio
- 6.10.5 Huachang Pharmaceutical Recent Developments
- 6.11 Xinyi Hanling Biological
- 6.11.1 Xinyi Hanling Biological Company Information
- 6.11.2 Xinyi Hanling Biological Business Overview
- 6.11.3 Xinyi Hanling Biological NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Xinyi Hanling Biological NAC (Acetylcisteine) Product Portfolio
- 6.11.5 Xinyi Hanling Biological Recent Developments
- 6.12 Shuguang Biological
- 6.12.1 Shuguang Biological Company Information
- 6.12.2 Shuguang Biological Business Overview
- 6.12.3 Shuguang Biological NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Shuguang Biological NAC (Acetylcisteine) Product Portfolio
- 6.12.5 Shuguang Biological Recent Developments
- 6.13 Scandinavian Formulas
- 6.13.1 Scandinavian Formulas Company Information
- 6.13.2 Scandinavian Formulas Business Overview
- 6.13.3 Scandinavian Formulas NAC (Acetylcisteine) Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Scandinavian Formulas NAC (Acetylcisteine) Product Portfolio
- 6.13.5 Scandinavian Formulas Recent Developments
7 North America by Country
- 7.1 North America NAC (Acetylcisteine) Sales by Country
- 7.1.1 North America NAC (Acetylcisteine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America NAC (Acetylcisteine) Sales by Country (2021-2026)
- 7.1.3 North America NAC (Acetylcisteine) Sales Forecast by Country (2027-2032)
- 7.2 North America NAC (Acetylcisteine) Market Size by Country
- 7.2.1 North America NAC (Acetylcisteine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America NAC (Acetylcisteine) Market Size by Country (2021-2026)
- 7.2.3 North America NAC (Acetylcisteine) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe NAC (Acetylcisteine) Sales by Country
- 8.1.1 Europe NAC (Acetylcisteine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe NAC (Acetylcisteine) Sales by Country (2021-2026)
- 8.1.3 Europe NAC (Acetylcisteine) Sales Forecast by Country (2027-2032)
- 8.2 Europe NAC (Acetylcisteine) Market Size by Country
- 8.2.1 Europe NAC (Acetylcisteine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe NAC (Acetylcisteine) Market Size by Country (2021-2026)
- 8.2.3 Europe NAC (Acetylcisteine) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific NAC (Acetylcisteine) Sales by Country
- 9.1.1 Asia-Pacific NAC (Acetylcisteine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific NAC (Acetylcisteine) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific NAC (Acetylcisteine) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific NAC (Acetylcisteine) Market Size by Country
- 9.2.1 Asia-Pacific NAC (Acetylcisteine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific NAC (Acetylcisteine) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific NAC (Acetylcisteine) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America NAC (Acetylcisteine) Sales by Country
- 10.1.1 South America NAC (Acetylcisteine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America NAC (Acetylcisteine) Sales by Country (2021-2026)
- 10.1.3 South America NAC (Acetylcisteine) Sales Forecast by Country (2027-2032)
- 10.2 South America NAC (Acetylcisteine) Market Size by Country
- 10.2.1 South America NAC (Acetylcisteine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America NAC (Acetylcisteine) Market Size by Country (2021-2026)
- 10.2.3 South America NAC (Acetylcisteine) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa NAC (Acetylcisteine) Sales by Country
- 11.1.1 Middle East and Africa NAC (Acetylcisteine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa NAC (Acetylcisteine) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa NAC (Acetylcisteine) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa NAC (Acetylcisteine) Market Size by Country
- 11.2.1 Middle East and Africa NAC (Acetylcisteine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa NAC (Acetylcisteine) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa NAC (Acetylcisteine) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 NAC (Acetylcisteine) Value Chain Analysis
- 12.1.1 NAC (Acetylcisteine) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 NAC (Acetylcisteine) Production Mode & Process
- 12.2 NAC (Acetylcisteine) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 NAC (Acetylcisteine) Distributors
- 12.2.3 NAC (Acetylcisteine) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst